MEDARTIS AG

Medartis Holding AG is a Swiss-based orthopaedic medical device manufacturer specializing in implants and surgical instruments for head and extremity surgery. The company operates globally with subsidiaries in Germany, UK, Switzerland, Spain, France, Mexico, USA, Poland, Austria, Japan, Australia, and Brazil. The product portfolio is organized into four primary divisions: CMF (craniomaxillofacial) solutions for midface, mandible, and orthognathic procedures; Upper Extremities (Aptus line) covering hand, wrist, forearm, elbow, and shoulder indications; Lower Extremities including foot and ankle systems; and CMX, a customization service offering bespoke implants, saws, and drill guides for complex cases. The Aptus product line includes systems such as the Distal Radius and Distal Ulna System 2.5, Hand 1.2–2.3, and Hallux System 2.8. Medartis reported 2025 total sales of CHF 269.3 million with 15.7% organic growth and a core EBITDA margin exceeding 18%, indicating significant market presence. The company is listed on the SIX Swiss Exchange (ticker: MED) and serves hospitals, surgical centers, and orthopaedic practices globally. Regulatory compliance and clinical research partnerships support product credibility in the orthopaedic implant market.